Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors
Open Access
- 21 July 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 123 (7) , 1556-1564
Abstract
To better understand the molecular pathogenesis of neuroendocrine tumors (NET), we investigated the molecular and clinical characteristics of malignant poorly differentiated colorectal NET and compared these findings with sporadic CRC and well‐differentiated benign and malignant fore‐/midgut NET. Tumors were analyzed and correlated for microsatellite instability (MSI) and the CpG island methylator phenotype (CIMP). NET were scored for proliferation using Ki‐67. A total of 34 malignant poorly differentiated colorectal NET, 38 well‐differentiated benign and malignant fore‐/midgut‐NET and 150 sporadic colorectal cancers (CRC) with known MSI status were investigated. Among the sporadic CRC, CIMP was significantly correlated with MSI‐high (MSI‐H) (p < 0.001). Of the 34 colorectal NET, 0/1 of the MSI‐H, 3/5 (60%) of the MSI‐L and 13/19 (68%) of the MSS tumors were CIMP+ (p = 0.17). Of the fore‐/midgut‐NET, none was MSI‐H. 20/34 (59%) colorectal NET vs. 11/38 (29%) fore‐/midgut‐NET were CIMP+ (p = 0.01). The Ki‐67 index was significantly higher in poorly differentiated colorectal NET compared to the less malignant fore‐/midgut‐NET (p < 0.0001). Besides the location in the colon, Ki‐67 predicted poor outcome in NET (p < 0.0001). CIMP status did not affect survival. In NET, p16 methylation predicted a poor outcome (p = 0.0004). We conclude that molecular pathogenesis in sporadic CRC and poorly differentiated colorectal NET is different despite some similarities. Main differences between malignant well‐differentiated and poorly differentiated NET are the Ki‐67 proliferation rate and differential methylation in tumor‐associated genes. Predictors of a poor outcome in patients with NET are poor differentiation, a high Ki‐67 index and p16 methylation.Keywords
This publication has 45 references indexed in Scilit:
- The CpG Island Methylator Phenotype and Chromosomal Instability Are Inversely Correlated in Sporadic Colorectal CancerGastroenterology, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor DiseaseNeuroendocrinology, 2005
- BRAFGene Mutations Are Rare Events in Gastroenteropancreatic Neuroendocrine TumorsAmerican Journal of Clinical Pathology, 2005
- Microsatellite instability and gene mutations in transforming growth factor‐beta type II receptor are absent in small bowel carcinoid tumorsCancer, 2005
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancreatic TractClinical Cancer Research, 2004
- Proliferation of antigen MIB-1 in metastatic carcinoid tumours removed at liver transplantationEuropean Journal of Gastroenterology & Hepatology, 2003
- Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisationGut, 2001
- Mutation and Expression Analyses Reveal Differential Subcellular Compartmentalization of PTEN in Endocrine Pancreatic Tumors Compared to Normal Islet CellsThe American Journal of Pathology, 2000